Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome

Berretta, Roberto; Marchesi, Federico; Volpi, Lavinia; Ricotta, Giulio; Monica, Michela; Sozzi, Giulio; Serio, Maurizio Di; Mautone, Daniele

doi:10.1016/j.tjog.2016.04.010

Cited by 14 publications

(19 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two recent publications evaluated multiple bowel resections in ovarian cancer, including one from Germany [ 16 ] and one from Korea [ 22 ]. We noticed that the interval-debulking rate (IDS) was relatively lower in our study (17.3%) and other similar studies (no IDS in Peiretti et al [ 28 ]; 19.3% in Berretta et al[ 14 ]). The possible explanation for this might be that the bowel resection rate might be lower in patients after neoadjuvant chemotherapy.…”

Section: Discussionsupporting

confidence: 54%

See 1 more Smart Citation

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients

Wang²,

Chen

et al. 2022

BMC Surg

View full text Add to dashboard Cite

Background To review the utilization of bowel resection in ovarian cancer surgery in our institution. Methods All ovarian cancer patients who received bowel resection between 2006/01 and 2018/12 were identified. Postoperative morbidities were assessed according to the Clavien–Dindo classification (CDC). Results There were 182 patients in the anastomosis group and 100 patients in the ostomy group, yielding a total of 282 patients. The median age was 57 years, and most patients had high-grade serous histology (88.7%). Forty-nine (17.3%) patients received neoadjuvant chemotherapy. During the operation, 78.7% of patients had ascites, and the median volume was 800 mL. Extensive bowel resection (at least two-segment) and upper abdominal operation were performed in 29 (10.2%) and 69 (24.4%) patients, respectively. The rectosigmoid colon was the most commonly resected (83.8%) followed by right hemicolectomy (5.9%) and small bowel resection (2.8%). No macroscopic residual disease was observed in 42.9% of the patients, whereas 87.9% had residual disease ≤ 1 cm. Among the entire cohort, 23.0% (65/282) experienced different complications. Severe complications (CDC 3–5) accounted for 9.2% of complications and were mostly categorized as pleural effusion requiring drainage (3.5%) followed by wound dehiscence requiring delayed repair in the operating room (1.8%). Nine patients experienced anastomotic leakage (AL): one in the ostomy group with extensive bowel resection and eight in the anastomosis group. The overall AL rate was 4.2% (9/212) per anastomosis. Conclusions The execution of bowel resection as part of debulking surgery in patients with newly diagnosed ovarian cancer resulted in a severe morbidity rate of 9.2%.

show abstract

Section: Discussionsupporting

confidence: 54%

“…Therefore, radical bowel resection during debulking surgery for ovarian cancer patients with bowel involvement is recommended [ 18 ]. The authors also presented that pelvic posterior exenteration with retrograde radical hysterectomy has the benefit of good preservation of ladder and colorectal functions [ 14 ].…”

Section: Introductionmentioning

confidence: 99%

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients

Wang²,

Chen

et al. 2022

BMC Surg

View full text Add to dashboard Cite

show abstract

“…8,356–376 Overall, 102,460 patients were enrolled in non-IBD studies (66.7% women) and 8289 in IBD studies (63.9% women), with the number of patients per study ranging from six to 47,714. Among non-IBD trials there were 137 prospective cohort studies, 48,50–53,58,59,61,62,64,68–72, 74–76,79–81,93,103,104,107,110–113,119,120,124–126,128,131,135,137, 142–145,149,151,153,…”

Section: Resultsmentioning

confidence: 99%

“…After careful evaluation of full‐text papers 27 studies were excluded: 15 studies 23–37 did not evaluate FI assessment, six manuscripts 38–43 were just protocols, five were paediatric studies, 44–48 and one trial 49 had an inappropriate study design. Finally, 328 studies were included in our review: 306 studies…”

Section: Resultsmentioning

confidence: 99%

“…Overall, 102,460 patients were enrolled in non‐IBD studies (66.7% women) and 8289 in IBD studies (63.9% women), with the number of patients per study ranging from six to 47,714. Among non‐IBD trials there were 137 prospective cohort studies, 48 , 50–53 , 58 , 59 , 61 , 62 , 64 , 68–72 , 74–76 , 79–81 , 93 , 103 , 104 , 107 , 110–113 , 119 , 120 , 124–126 , 128 , 131 , 135 , 137 , 142–145 , 149 , 151 , 153 , 157–163 , 166 , 168 , 169 , 171–174 , 176–182 , 187 , 190 , 192 , 197 , 198 , 202 , 204 , 207 , 211–214 , 216 , 218 , 219 , 221 , 222 , 224 , 225 , 231 , 234 , 235 ,…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

et al. 2020

View full text Add to dashboard Cite

Background Fecal incontinence is a disabling condition affecting up to 20% of women. Objective We investigated fecal incontinence assessment in both inflammatory bowel disease and non-inflammatory bowel disease patients to propose a diagnostic approach for inflammatory bowel disease trials. Methods We searched on Pubmed, Embase and Cochrane Library for all studies on adult inflammatory bowel disease and non-inflammatory bowel disease patients reporting data on fecal incontinence assessment from January 2009 to December 2019. Results In total, 328 studies were included; 306 studies enrolled non-inflammatory bowel disease patients and 22 studies enrolled inflammatory bowel disease patients. In non-inflammatory bowel disease trials the most used tools were the Wexner score, fecal incontinence quality of life questionnaire, Vaizey score and fecal incontinence severity index (in 187, 91, 62 and 33 studies). Anal manometry was adopted in 41.2% and endoanal ultrasonography in 34.0% of the studies. In 142 studies (46.4%) fecal incontinence evaluation was performed with a single instrument, while in 64 (20.9%) and 100 (32.7%) studies two or more instruments were used. In inflammatory bowel disease studies the Wexner score, Vaizey score and inflammatory bowel disease quality of life questionnaire were the most commonly adopted tools (in five (22.7%), five (22.7%) and four (18.2%) studies). Anal manometry and endoanal ultrasonography were performed in 45.4% and 18.2% of the studies. Conclusion Based on prior validation and experience, we propose to use the Wexner score as the first step for fecal incontinence assessment in inflammatory bowel disease trials. Anal manometry and/or endoanal ultrasonography should be taken into account in the case of positive questionnaires.

show abstract

Quality of Life and Patient‐Reported Outcome Measures Following Pelvic Exenteration

Steffens

Koh

Solomon

2021

Surgical Management of Advanced Pelvic Cancer

View full text Add to dashboard Cite

Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome

Cited by 14 publications

References 33 publications

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

Quality of Life and Patient‐Reported Outcome Measures Following Pelvic Exenteration

Contact Info

Product

Resources

About